Article

Combining ring segments and cross-linking yields good results

Implantation of intracorneal ring segments (ICR) can be combined with a UV cross-linking procedure.

Implantation of intracorneal ring segments (ICR) can be combined with a UV cross-linking procedure, according to Omid Kermani and colleagues from a private eye clinic in Schildergasse, Germany.

Between 2005 and 2006, four keratoconic eyes underwent combined UV collagen cross-linking and ICR implantation. Following femtosecond laser assisted preparation of the corneal tunnel, ICRs were implanted. Two to six months later, if visual acuity (VA) and refraction were stable, a cross-linking procedure was performed.

ICR implantation resulted in an average best corrected visual acuity (BCVA) gain of two lines and an average uncorrected visual acuity (UCVA) gain of six lines. Collagen cross-linking did not change UCVA by three months postoperatively but BCVA increased by an average of one line. Although the results were stable initially, two eyes did demonstrate a decrease in effect from the ICR implants. In these cases, the single ring segment was replaced by two thicker segments, which helped improve VA by up to three lines.

The results demonstrate that ICR implantation and UV cross-linking can be combined, however, further studies are needed to show which combination of these procedures produces the best results.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.